JP2024515181A5 - - Google Patents
Info
- Publication number
- JP2024515181A5 JP2024515181A5 JP2023563940A JP2023563940A JP2024515181A5 JP 2024515181 A5 JP2024515181 A5 JP 2024515181A5 JP 2023563940 A JP2023563940 A JP 2023563940A JP 2023563940 A JP2023563940 A JP 2023563940A JP 2024515181 A5 JP2024515181 A5 JP 2024515181A5
- Authority
- JP
- Japan
- Prior art keywords
- il15rβ
- csfrβ
- domain
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021088111 | 2021-04-19 | ||
| CNPCT/CN2021/088111 | 2021-04-19 | ||
| PCT/CN2022/087572 WO2022222905A1 (en) | 2021-04-19 | 2022-04-19 | Chimeric cytokine receptors and uses thereof in cellular therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515181A JP2024515181A (ja) | 2024-04-05 |
| JP2024515181A5 true JP2024515181A5 (enExample) | 2025-04-18 |
Family
ID=83721965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563940A Pending JP2024515181A (ja) | 2021-04-19 | 2022-04-19 | キメラサイトカイン受容体及びその細胞療法における使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240180964A1 (enExample) |
| EP (1) | EP4326771A4 (enExample) |
| JP (1) | JP2024515181A (enExample) |
| KR (1) | KR20240017338A (enExample) |
| CN (1) | CN117279945A (enExample) |
| AU (1) | AU2022262046A1 (enExample) |
| CA (1) | CA3217252A1 (enExample) |
| WO (1) | WO2022222905A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024254279A2 (en) * | 2023-06-06 | 2024-12-12 | The Johns Hopkins University | Velocity receptor expressing immune cells and uses thereof |
| WO2025026347A1 (en) * | 2023-07-31 | 2025-02-06 | Nanjing Legend Biotech Co., Ltd. | Chimeric cytokine receptors and methods of use thereof |
| CN118853563B (zh) * | 2024-07-15 | 2026-04-14 | 深圳泽医细胞治疗集团有限公司 | 免疫细胞培养试剂盒、γδT细胞的培养方法及应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201505858VA (en) * | 2013-01-28 | 2015-09-29 | St Jude Childrens Res Hospital | A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease |
| GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| SG10201912519VA (en) * | 2016-04-01 | 2020-02-27 | Kite Pharma Inc | Chimeric receptors and methods of use thereof |
| EP4119552A1 (en) * | 2017-02-08 | 2023-01-18 | Dana-Farber Cancer Institute, Inc. | Regulating chimeric antigen receptors |
| CN109503715B (zh) * | 2017-09-15 | 2023-12-15 | 科济生物医药（上海）有限公司 | Il-4r的融合蛋白及其应用 |
| WO2019118885A1 (en) * | 2017-12-14 | 2019-06-20 | Bluebird Bio, Inc. | Nkg2d daric receptors |
| BR112020011017A2 (pt) * | 2017-12-22 | 2020-11-17 | Fate Therapeutics, Inc. | células efetoras imunes intensificadas e uso das mesmas |
| WO2019160956A1 (en) * | 2018-02-13 | 2019-08-22 | Novartis Ag | Chimeric antigen receptor therapy in combination with il-15r and il15 |
| CA3118889A1 (en) * | 2018-11-07 | 2020-05-14 | Sotio, LLC | Anti-gpc3 chimeric antigen receptors (cars) in combination with trans co-stimulatory molecules and therapeutic uses thereof |
| IL285941B1 (en) * | 2019-03-01 | 2026-08-01 | Allogene Therapeutics Inc | Cytokine chemoreceptors bearing the PD-1 ECTODOMAIN |
| IL328846A (en) * | 2019-03-01 | 2026-08-01 | Allogene Therapeutics Inc | Constitutively active chimeric cytokine receptors and compounds comprising them for the treatment of cancer and autoimmune diseases |
| BR112022003553A2 (pt) * | 2019-08-30 | 2022-05-24 | Allogene Therapeutics Inc | Receptores de citocina quiméricos compreendendo domínios de ligação a tgf beta |
| CN111218426A (zh) * | 2020-02-26 | 2020-06-02 | 华东师范大学 | 一种克服肿瘤微环境car-t细胞的制备及其用途 |
-
2022
- 2022-04-19 CA CA3217252A patent/CA3217252A1/en active Pending
- 2022-04-19 US US18/286,684 patent/US20240180964A1/en active Pending
- 2022-04-19 CN CN202280028311.1A patent/CN117279945A/zh active Pending
- 2022-04-19 KR KR1020237035152A patent/KR20240017338A/ko active Pending
- 2022-04-19 EP EP22791013.0A patent/EP4326771A4/en active Pending
- 2022-04-19 WO PCT/CN2022/087572 patent/WO2022222905A1/en not_active Ceased
- 2022-04-19 AU AU2022262046A patent/AU2022262046A1/en active Pending
- 2022-04-19 JP JP2023563940A patent/JP2024515181A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7320560B2 (ja) | 治療免疫細胞の有効性を改良するための方法 | |
| JP7490915B2 (ja) | 抗メソテリンキメラ抗原受容体（ｃａｒ）構築物及びその使用 | |
| JP2025065142A5 (enExample) | ||
| JP2022113880A5 (enExample) | ||
| JP2019537433A5 (enExample) | ||
| KR102607152B1 (ko) | 키메라 항원 수용체 | |
| JP2021515598A5 (enExample) | ||
| JP2020511136A5 (enExample) | ||
| JP2021525524A5 (enExample) | ||
| JP2019536452A5 (enExample) | ||
| JP2021514631A5 (enExample) | ||
| JP2020517295A5 (enExample) | ||
| JP2021519580A5 (enExample) | ||
| EP3829312A1 (en) | Multi-function and multi-targeting car system and methods for use thereof | |
| JP2020513828A5 (enExample) | ||
| JP2017530694A5 (enExample) | ||
| US11945878B2 (en) | Switch molecule and switchable chimeric antigen receptor | |
| JP2024534471A5 (enExample) | ||
| JP2021532742A5 (enExample) | ||
| CN107735407A (zh) | 治疗剂 | |
| JP2018515123A5 (enExample) | ||
| JP2017522879A5 (enExample) | ||
| EP3568406A1 (en) | T cells expressing a chimeric antigen receptor | |
| JP2017518071A5 (enExample) | ||
| JP2024534417A5 (enExample) |